<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Pbs-Biotech on Bioecon</title><link>https://en.bioecon.ru/companies/pbs-biotech/</link><description>Recent content in Pbs-Biotech on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Fri, 14 Aug 2026 22:34:37 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/companies/pbs-biotech/index.xml" rel="self" type="application/rss+xml"/><item><title>High-cell-density culture systems</title><link>https://en.bioecon.ru/technology/high-cell-density-culture-systems/</link><pubDate>Fri, 14 Aug 2026 15:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/high-cell-density-culture-systems/</guid><description>Bioreactor hardware engineered to sustain far higher viable-cell densities than a conventional stirred tank — Repligen&amp;rsquo;s XCell ATF perfusion system (100M+ cells/mL), PBS Biotech&amp;rsquo;s Vertical-Wheel bioreactors, Univercells Technologies&amp;rsquo; scale-X fixed-bed platform, and Cellexus&amp;rsquo;s CellMaker airlift bioreactors — the equipment layer that lets a fed-batch or perfusion process pack more cells and more product into the same reactor volume.</description></item></channel></rss>